Results for tag: "Epoprostenol"

Epoprostenol is a cardiovascular drug used to treat pulmonary arterial hypertension (PAH). It is a prostacyclin analogue that works by relaxing the blood vessels in the lungs, allowing for improved blood flow and oxygenation. It is administered intravenously or subcutaneously, and is typically used in combination with other drugs to treat PAH. Epoprostenol is also used to treat other conditions such as Raynaud's phenomenon and scleroderma. Epoprostenol is a relatively new drug, having been approved by the US Food and Drug Administration in 1995. It is available in both generic and brand name forms, and is typically prescribed by a cardiologist or pulmonologist. The epoprostenol market is highly competitive, with several major pharmaceutical companies offering the drug. These include GlaxoSmithKline, Pfizer, Novartis, and Bayer. Additionally, there are several generic manufacturers that produce the drug, such as Mylan, Teva, and Sandoz. Show Less Read more